Genetically Modified Mice Researching Celiac Disease Medications at the University of Mainz

Researchers at the University of Mainz are developing new medications for celiac disease. As part of this important research, an animal model is being used: genetically modified mice. These models serve to replicate and investigate the complex mechanisms of celiac disease. The focus of the current investigation is on understanding the underlying immune reactions that play a role in this condition. This in-depth research into the complex processes aims to gain a clear picture of the immune response. The use of these advanced animal models makes it possible to analyze disease mechanisms precisely, which is crucial for developing new treatment approaches. The ultimate goal of this scientific work is to develop effective and targeted therapies that can later be used in humans.